762680

    506414

    FERMENTA

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Fermenta Biotech Ltd Share Price Today

    FERMENTA BIOTECH LTD. made its stock market debut on 20 April 2026 and is currently trading at ₹559.65, up by ₹7.05 from the previous close. The stock touched an intraday high of ₹560.75 and a low of ₹546.20 during the latest trading session.

    Fermenta Biotech Ltd performance

    Today’s low Today’s high
    ₹ 546.20 ₹ 560.75
    ₹ 548.40
    52 week low 52 week high
    ₹ 248.85 ₹ 564.80
    ₹ 548.40
    Open Price ₹ 555.35
    Prev. Close ₹ 552.60
    Volume (Shares) 6789.00
    Total traded value ₹ 37.23
    Upper Circuit ₹ 663.10
    Lower Circuit ₹ 442.10
    info

    Investment Returns

    Over 1 Month 39.88% Over 3 Months 83.43% Over 6 Months 73.55% Over 1 Year 0.00%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Fermenta Biotech Ltd fundamentals


    • Market cap (Cr) 1,615.80
    • P/E Ratio (TTM) 25.26
    • Beta 0.33
    • Book Value / share 143.79
    • Return on equity 16.01%
    • EPS (TTM) 18.77
    • Dividend yield 0.66%
    • Net profit/quarter (Cr) 21.57
    info icon alternate text
    • Market cap (Cr) 1,633.40
    • P/E Ratio (TTM) 25.26
    • Beta 0.78
    • Book Value / share 143.79
    • Return on equity 16.01%
    • EPS (TTM) 18.77
    • Dividend yield 0.66%
    • Net profit/quarter (Cr) 21.57
    info icon alternate text

    Fermenta Biotech Ltd Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 109.88
    Operating Expense 95.89
    Net Profit 21.57
    Net Profit Margin (%) 19.63
    Earnings Per Share (EPS) 5.26
    EBITDA 37.01
    Effective Tax Rate (%) 26.02
    Particulars DEC 2025 (Values in Cr)
    Revenue 114.24
    Operating Expense 98.98
    Net Profit 11.76
    Net Profit Margin (%) 10.29
    Earnings Per Share (EPS) 4.56
    EBITDA 24.79
    Effective Tax Rate (%) 29.11
    Particulars SEP 2025 (Values in Cr)
    Revenue 107.12
    Operating Expense 91.87
    Net Profit 14.72
    Net Profit Margin (%) 13.74
    Earnings Per Share (EPS) 5.05
    EBITDA 28.49
    Effective Tax Rate (%) 29.12
    Particulars JUN 2025 (Values in Cr)
    Revenue 119.02
    Operating Expense 105.15
    Net Profit 16.23
    Net Profit Margin (%) 13.63
    Earnings Per Share (EPS) 5.57
    EBITDA 31.38
    Effective Tax Rate (%) 28.56
    Particulars MAR 2025 (Values in Cr)
    Revenue 122.04
    Operating Expense 97.94
    Net Profit 29.31
    Net Profit Margin (%) 24.01
    Earnings Per Share (EPS) 10.05
    EBITDA 36.56
    Effective Tax Rate (%) -4.79
    Particulars MAR 2026 (Values in Cr)
    Revenue 450.25
    Operating Expense 391.87
    Net Profit 64.28
    Net Profit Margin (%) 14.27
    Earnings Per Share (EPS) 20.43
    EBITDA 121.66
    Effective Tax Rate (%) 27.96
    Particulars MAR 2025 (Values in Cr)
    Revenue 430.53
    Operating Expense 367.78
    Net Profit 67.62
    Net Profit Margin (%) 15.70
    Earnings Per Share (EPS) 23.18
    EBITDA 111.79
    Effective Tax Rate (%) 9.15
    Particulars MAR 2024 (Values in Cr)
    Revenue 307.09
    Operating Expense 310.85
    Net Profit -18.74
    Net Profit Margin (%) -6.10
    Earnings Per Share (EPS) -3.37
    EBITDA 36.14
    Effective Tax Rate (%) -306.72
    Particulars MAR 2023 (Values in Cr)
    Revenue 328.91
    Operating Expense 335.76
    Net Profit -57.00
    Net Profit Margin (%) -17.32
    Earnings Per Share (EPS) -19.75
    EBITDA -12.68
    Effective Tax Rate (%) 1.67
    Particulars MAR 2022 (Values in Cr)
    Revenue 387.96
    Operating Expense 352.93
    Net Profit 30.24
    Net Profit Margin (%) 7.79
    Earnings Per Share (EPS) 10.48
    EBITDA 83.46
    Effective Tax Rate (%) 28.97
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 141.68
    ROE % 18.27
    ROCE % 20.68
    Total Debt to Total Equity 0.30
    EBITDA Margin 24.78
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 124.33
    ROE % 23.45
    ROCE % 20.20
    Total Debt to Total Equity 0.39
    EBITDA Margin 26.05
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 100.04
    ROE % -5.82
    ROCE % 2.96
    Total Debt to Total Equity 0.59
    EBITDA Margin 11.93
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 109.27
    ROE % -7.57
    ROCE % -0.19
    Total Debt to Total Equity 0.67
    EBITDA Margin 7.74
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 129.00
    ROE % 4.11
    ROCE % 7.36
    Total Debt to Total Equity 0.64
    EBITDA Margin 17.69
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 147.47
    ROE % 16.01
    ROCE % 18.77
    Total Debt to Total Equity 0.28
    EBITDA Margin 27.22
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 130.26
    ROE % 19.48
    ROCE % 17.61
    Total Debt to Total Equity 0.37
    EBITDA Margin 26.11
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 108.83
    ROE % -2.38
    ROCE % 4.10
    Total Debt to Total Equity 0.55
    EBITDA Margin 14.92
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 116.45
    ROE % 0.84
    ROCE % 3.77
    Total Debt to Total Equity 0.63
    EBITDA Margin 14.52
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 137.26
    ROE % 7.89
    ROCE % 9.65
    Total Debt to Total Equity 0.62
    EBITDA Margin 21.74
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 41.34
    Total Assets 647.93
    Total Liabilities 647.93
    Total Equity 400.54
    Share Outstanding 2
    Price to Book Ratio 2.16
    Return on Assets (%) 11.07
    Return on Capital (%) 14.09
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 71.69
    Total Assets 614.47
    Total Liabilities 614.47
    Total Equity 358.51
    Share Outstanding 2
    Price to Book Ratio 2.10
    Return on Assets (%) 12.50
    Return on Capital (%) 16.43
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 59.83
    Total Assets 547.83
    Total Liabilities 547.83
    Total Equity 285.16
    Share Outstanding 2
    Price to Book Ratio 1.39
    Return on Assets (%) -4.20
    Return on Capital (%) -5.52
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 58.32
    Total Assets 636.51
    Total Liabilities 636.51
    Total Equity 312.56
    Share Outstanding 2
    Price to Book Ratio 0.92
    Return on Assets (%) -8.02
    Return on Capital (%) -9.65
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 33.60
    Total Assets 706.84
    Total Liabilities 706.84
    Total Equity 371.45
    Share Outstanding 2
    Price to Book Ratio 1.50
    Return on Assets (%) 2.18
    Return on Capital (%) 2.54
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 18.02
    Total Assets 652.35
    Total Liabilities 652.35
    Total Equity 422.81
    Share Outstanding 2
    Price to Book Ratio 2.16
    Return on Assets (%) 9.85
    Return on Capital (%) 12.09
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 61.95
    Total Assets 622.46
    Total Liabilities 622.46
    Total Equity 379.95
    Share Outstanding 2
    Price to Book Ratio 2.10
    Return on Assets (%) 10.86
    Return on Capital (%) 13.82
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 56.63
    Total Assets 564.57
    Total Liabilities 564.57
    Total Equity 314.22
    Share Outstanding 2
    Price to Book Ratio 1.39
    Return on Assets (%) -3.31
    Return on Capital (%) -4.2
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 55.11
    Total Assets 663.85
    Total Liabilities 663.85
    Total Equity 336.05
    Share Outstanding 2
    Price to Book Ratio 0.92
    Return on Assets (%) -8.58
    Return on Capital (%) -10.31
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 30.74
    Total Assets 712.64
    Total Liabilities 712.64
    Total Equity 395.97
    Share Outstanding 2
    Price to Book Ratio 1.50
    Return on Assets (%) 4.24
    Return on Capital (%) 4.78
    Particulars MAR 2026 (Values in Cr)
    Net Income 95.86
    Cash from Operations 109.25
    Cash from Investing -42.99
    Cash from Financing -42.28
    Net change in Cash 7.54
    Free Cash Flow 139.58
    Particulars MAR 2025 (Values in Cr)
    Net Income 83.20
    Cash from Operations 43.67
    Cash from Investing -0.15
    Cash from Financing -50.86
    Net change in Cash -10.12
    Free Cash Flow 65.80
    Particulars MAR 2024 (Values in Cr)
    Net Income -9.87
    Cash from Operations 104.32
    Cash from Investing -15.49
    Cash from Financing -90.85
    Net change in Cash -1.00
    Free Cash Flow 123.53
    Particulars MAR 2023 (Values in Cr)
    Net Income -51.30
    Cash from Operations 112.90
    Cash from Investing -55.40
    Cash from Financing -41.37
    Net change in Cash 19.31
    Free Cash Flow 153.38
    Particulars MAR 2022 (Values in Cr)
    Net Income 26.94
    Cash from Operations 52.74
    Cash from Investing -26.03
    Cash from Financing -21.57
    Net change in Cash -4.17
    Free Cash Flow 89.87
    Particulars MAR 2026 (Values in Cr)
    Net Income 89.24
    Cash from Operations 98.93
    Cash from Investing -44.49
    Cash from Financing -42.14
    Net change in Cash -4.02
    Free Cash Flow 129.24
    Particulars MAR 2025 (Values in Cr)
    Net Income 74.42
    Cash from Operations 36.59
    Cash from Investing 0.40
    Cash from Financing -50.90
    Net change in Cash -16.67
    Free Cash Flow 58.73
    Particulars MAR 2024 (Values in Cr)
    Net Income -4.60
    Cash from Operations 104.00
    Cash from Investing -15.14
    Cash from Financing -90.85
    Net change in Cash -0.98
    Free Cash Flow 123.21
    Particulars MAR 2023 (Values in Cr)
    Net Income -57.97
    Cash from Operations 119.40
    Cash from Investing -63.53
    Cash from Financing -41.25
    Net change in Cash 18.96
    Free Cash Flow 159.89
    Particulars MAR 2022 (Values in Cr)
    Net Income 42.56
    Cash from Operations 59.68
    Cash from Investing -32.46
    Cash from Financing -21.76
    Net change in Cash -3.81
    Free Cash Flow 96.81
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.93 18.23 2.12 336.65 23.12 45.50
    BLISS GVS PHARMA LTD 493.60 39.74 4.39 5244.20 118.35 552.90
    CIPLA LTD 1475.00 33.30 3.46 119157.18 1165.55 1672.20
    GLAXOSMITHKLINE PHARMA LT 2579.60 41.51 19.27 43699.98 2088.00 2899.90
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.93 30.72 5.65 336.65 23.12 45.50
    AMRUTANJAN HEALTH CARE LTD. 519.90 23.30 4.05 1503.06 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8091.35 105.74 23.17 20228.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 493.60 53.42 4.53 5244.20 118.35 552.90

    Fermenta Biotech Ltd shareholding pattern

    Holding
    35.52%
    64.08%
    0.34%
    0.04%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Fermenta Biotech Ltd Technicals Summary

    549.00 -0.65 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 519.20
    • 26 Days 443.40
    • 10 Days 491.50
    • 50 Days 401.20
    • 12 Days 483.30
    • 100 Days 356.90
    • 20 Days 457.90
    • 200 Days 356.90
    551.50 PIVOT
    First Support 546.00 First Resistance 558.10 Second Support 539.40 Second Resistance 563.60 Third Support 533.90 Third Resistance 570.20
    RSI 77.62 ADX 36.77 MACD 42.50 Williams % R -6.92 Commodity Channel Index (CCI) 179.38
    Date 2026-08-06 Week 103385.00 Same Day 36658.00 Month 121095.00
    1 Year 0.34 3 Year 0.30
    Over 1 Month
    39.88% down
    Over 1 Year
    0.00% down
    Over 3 Months
    83.43% down
    Over 3 Years
    0.00% down
    Over 6 Months
    73.55% down
    Over 5 Years
    0.00% down

    Fermenta Biotech Ltd Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    05 Aug 2026 3.75 Final 05 Aug 2026 Equity shares
    06 Aug 2025 2.5 Final 06 Aug 2025 Equity shares
    06 Aug 2024 1.25 Final 06 Aug 2024 Equity shares
    22 Sep 2023 1.25 Final 22 Sep 2023 Equity shares
    04 Aug 2022 1.25 Final 05 Aug 2022 Equity shares
    25 Aug 2021 2.5 Final 27 Aug 2021 Equity shares
    22 Nov 2019 5.0 Interim 25 Nov 2019 Equity shares
    28 Jun 2019 1.25 Final 02 Jul 2019 Equity shares
    19 Sep 2018 1.25 Final 22 Sep 2018 Equity shares
    21 Sep 2017 2.5 Final 23 Sep 2017 Equity shares
    19 Sep 2016 2.5 Final 21 Sep 2016 Equity shares
    10 Sep 2014 2.5 Final 12 Sep 2014 Equity shares
    24 Feb 2014 7.5 Interim 25 Feb 2014 Equity shares
    13 Sep 2012 15.0 Final 15 Sep 2012 Equity shares
    05 Jul 2012 15.0 Interim 06 Jul 2012 Equity shares
    23 Feb 2012 15.0 Interim 24 Feb 2012 Equity shares
    15 Sep 2011 10.0 Final 17 Sep 2011 Equity shares
    22 Feb 2011 15.0 Interim 23 Feb 2011 Equity shares
    15 Sep 2010 7.5 Final 17 Sep 2010 Equity shares
    03 Jun 2010 7.5 Interim 04 Jun 2010 Equity shares
    17 Sep 2009 7.5 Final 19 Sep 2009 Equity shares
    29 Jun 2009 7.5 Interim 30 Jun 2009 Equity shares
    18 Sep 2008 10.0 Final 20 Sep 2008 Equity shares
    06 Sep 2007 5.0 Final 08 Sep 2007 Equity shares
    08 Sep 2005 0.0 Final 10 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    14 Feb 2020 13 Feb 2020 2:1
    09 Aug 2018 08 Aug 2018 1:1
    Ex-Date Old FV NEW FV Record Date
    08 Aug 2018 10.0 5.0 09 Aug 2018
    Dividend date Dividend amount Dividend type Record date Instrument type
    05 Aug 2026 3.75 Final 05 Aug 2026 Equity shares
    06 Aug 2025 2.5 Final 06 Aug 2025 Equity shares
    06 Aug 2024 1.25 Final 06 Aug 2024 Equity shares
    22 Sep 2023 1.25 Final 22 Sep 2023 Equity shares
    04 Aug 2022 1.25 Final 05 Aug 2022 Equity shares
    25 Aug 2021 2.5 Final 27 Aug 2021 Equity shares
    22 Nov 2019 5.0 Interim 25 Nov 2019 Equity shares
    28 Jun 2019 1.25 Final 02 Jul 2019 Equity shares
    19 Sep 2018 1.25 Final 22 Sep 2018 Equity shares
    21 Sep 2017 2.5 Final 23 Sep 2017 Equity shares
    19 Sep 2016 2.5 Final 21 Sep 2016 Equity shares
    10 Sep 2014 2.5 Final 12 Sep 2014 Equity shares
    24 Feb 2014 7.5 Interim 25 Feb 2014 Equity shares
    13 Sep 2012 15.0 Final 15 Sep 2012 Equity shares
    05 Jul 2012 15.0 Interim 06 Jul 2012 Equity shares
    23 Feb 2012 15.0 Interim 24 Feb 2012 Equity shares
    15 Sep 2011 10.0 Final 17 Sep 2011 Equity shares
    22 Feb 2011 15.0 Interim 23 Feb 2011 Equity shares
    15 Sep 2010 7.5 Final 17 Sep 2010 Equity shares
    03 Jun 2010 7.5 Interim 04 Jun 2010 Equity shares
    17 Sep 2009 7.5 Final 19 Sep 2009 Equity shares
    29 Jun 2009 7.5 Interim 30 Jun 2009 Equity shares
    18 Sep 2008 10.0 Final 20 Sep 2008 Equity shares
    06 Sep 2007 5.0 Final 08 Sep 2007 Equity shares
    08 Sep 2005 0.0 Final 10 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    14 Feb 2020 13 Feb 2020 2:1
    09 Aug 2018 08 Aug 2018 1:1
    Ex-Date Old FV NEW FV Record Date
    08 Aug 2018 10.0 5.0 09 Aug 2018

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Fermenta Biotech Ltd?

    Answer Field

    Fermenta Biotech Ltd share price is for NSE ₹ 559.65 & for BSE ₹ 559.70 as on Aug 07 2026 10:55 AM.

    What is the Market Cap of Fermenta Biotech Ltd Share?

    Answer Field

    The market cap of Fermenta Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 07 2026 10:55 AM.

    What is the 52 Week High and Low of Fermenta Biotech Ltd?

    Answer Field

    The 52 Week High and Low of Fermenta Biotech Ltd for NSE is ₹ 564.80 and ₹ 248.85 and for BSE is ₹ 564.50 and ₹ 256.40.

    What is 1 year return for Fermenta Biotech Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of Fermenta Biotech Ltd Share?

    Answer Field

    As on Aug 07 2026 10:55 AM the price-to-earnings (PE) ratio for Fermenta Biotech Ltd share is 25.26.

    What is the PB ratio of Fermenta Biotech Ltd Share?

    Answer Field

    As on Aug 07 2026 10:55 AM, the price-to-book (PB) ratio for Fermenta Biotech Ltd share is 143.79.

    How to Buy Fermenta Biotech Ltd Share?

    Answer Field

    You can trade in Fermenta Biotech Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Fermenta Biotech Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Fermenta Biotech Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Fermenta Biotech Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |